Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre: Reassessment in the era of ancillary molecular diagnosis

Sarcoma

Volumn 2014, Issue , 2014, Pages

  Thway, Khin ^a   Wang, Jayson ^a   Mubako, Taka ^a   Fisher, Cyril ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; TUMOR VOLUME;

EID: 84920773301     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2014/686902     Document Type: Article

References (17)

1. A. L. Hartley, V. Blair, M. Harris et al., "Sarcomas in NorthWest England: II incidence," The British Journal of Cancer, vol. 64, no. 6, pp. 1145-1150, 1991.
2. "Improving Outcomes for People with Sarcoma," http://www .nice.org.uk/nicemedia/pdf/SarcomaFullGuidance.pdf.
3. C. Fisher, "Dataset for cancer histopathology reports on soft tissue sarcomas," Royal College of Pathologists, 2012, http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/G094 DatasetSoftTissue Mar14.pdf.
4. K.Thway and C. Fisher, "Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre," Sarcoma, vol. 2009,Article ID 741975, 7 pages, 2009.
5. J.M. Coindre,M. Trojani, G. Contesso et al., "Reproducibility of a histopathologic grading system for adult soft tissue sarcoma," Cancer, vol. 58, no. 2, pp. 306-309, 1986.
6. L. Guillou, J.M. Coindre, F. Bonichon et al., "Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma," Journal of Clinical Oncology, vol. 15, no. 1, pp. 350-362, 1997.
7. C. A. Presant, W. O. Russell, R. W. Alexander, and Y. S. Fu, "Soft-tissue and bone sarcoma histopathology peer review: The frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience," Journal of Clinical Oncology, vol. 4, no. 11, pp. 1658-1661, 1986.
8. T. A. Alvegard and N. O. Berg, "Histopathology peer review of high-grade soft tissue sarcoma: The Scandinavian Sarcoma Group experience," Journal of Clinical Oncology, vol. 7, no. 12, pp. 1845-1851, 1989.
9. M.Harris, A. L.Hartley, V. Blair et al., "Sarcomas in NorthWest England: I. Histopathological peer review," British Journal of Cancer, vol. 64, no. 2, pp. 315-320, 1991.
10. Z. K. Arbiser, A. L. Folpe, and S. W. Weiss, "Consultative (expert) second opinions in soft tissue pathology: Analysis of problem-prone diagnostic situations," The American Journal of Clinical Pathology, vol. 116, no. 4, pp. 473-476, 2001.
11. I. Ray-coquard, M. C.Montesco, J.M. Coindre et al., "Sarcoma: Concordance between initial diagnosis and centralized expert review in a population-based study within three European regions," Annals of Oncology, vol. 23, no. 9, Article IDmdr610, pp. 2442-2449, 2012.
12. A. Neuville, D. Ranchère-Vince, A. P. Dei Tos et al., "Impact of molecular analysis on the final sarcoma diagnosis: A study on 763 cases collected during a European epidemiological study," The American Journal of Surgical Pathology, vol. 37, no. 8, pp. 1259-1268, 2013.
13. N. D. Riddle, R. J. Gonzalez, J. A. Bridge, S. Antonia, andM.M. Bui, "A CD117 and CD34 immunoreactive sarcoma masquerading as a gastrointestinal stromal tumor: Diagnostic pitfalls of ancillary studies in sarcoma," Cancer Control, vol. 18, no. 3, pp. 152-159, 2011.
14. M. Sabah, M. Leader, and E. Kay, "The problem with KIT: Clinical implications and practical difficulties with CD117 immunostaining," Applied Immunohistochemistry and Molecular Morphology, vol. 11, no. 1, pp. 56-61, 2003.
15. I. Espinosa, C. H. Lee, M. K. Kim et al., "A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors," American Journal of Surgical Pathology, vol. 32, no. 2, pp. 210-218, 2008.
16. K.Watanabe, T. Kusakabe,N.Hoshi, A. Saito, and T. Suzuki, "h-Caldesmon in leiomyosarcoma and tumorswith smoothmuscle cell-like differentiation: Its specific expression in the smooth muscle cell tumor," Human Pathology, vol. 30, no. 4, pp. 392-396, 1999.
17. J.W.Carlson and C.D. M. Fletcher, "Immunohistochemistry for -catenin in the differential diagnosis of spindle cell lesions: Analysis of a series and review of the literature," Histopathology, vol. 51, no. 4, pp. 509-514, 2007.